Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters

Sponsor
William Beaumont Hospitals (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06074237
Collaborator
Merck Sharp & Dohme LLC (Industry)
112
1
1
17
6.6

Study Details

Study Description

Brief Summary

Unfortunately, only 40% of US pediatric residency programs reported in a survey that vaccine safety and counseling training is provided to residents. The success of a residency curriculum focused on communication strategies with patients hesitant to receive the influenza vaccine has been demonstrated, finding a decreased rate of vaccination refusal in the post curricular period. In a recent 2020 study, it demonstrated the positive impact of an online vaccine curriculum on resident vaccine knowledge and self-reported confidence in counseling vaccine hesitant patients.

Providers have the potential to impact a substantial pediatric patient population. The outpatient clinics where the residents included in this study care for patients had 9942 pediatric visits in 2021. Each visit is an opportunity to talk with families about vaccines, address concerns and to administer vaccines when needed. The hypothesize is that interactive educational interventions using the online training modules combined with the standardized patient encounters will increase resident vaccine knowledge and confidence, and enhance communication and counseling skills, thereby improving vaccination rates of Human Papilloma Virus (HPV), Influenza, Measles/Mumps/Rubella (MMR) and Coronavirus (COVID-19) in the Beaumont residency clinics.

Condition or Disease Intervention/Treatment Phase
  • Other: Immersive resident education
  • Other: Standardized patient (SP) encounter
N/A

Detailed Description

The World Health Organization (WHO) defines vaccine hesitancy (VH) as "the reluctance or refusal to vaccinate despite the availability of vaccines" and included it in the list of top ten threats to global health [WHO]. The coverage levels for most childhood vaccines remain high in the United States where data shows vaccination rate of >90% in 24-months-old children for Polio, MMR, Hepatitis B, and Varicella; >80% for Diphtheria, Tetanus, Pertussis, and 79.6% for Haemophilus Influenza type B (Hib) in 2019. However, studies demonstrated an uptrend in vaccine hesitancy. One national survey performed in 2009 involving randomly selected participants revealed 54% parents expressed concern regarding vaccine safety and 11.5% refused recommended vaccines, despite 90% respondents agreed vaccines are a good way to prevent diseases. A survey of pediatricians in Connecticut reported increased parental vaccination concerns and refusals compared with 10 years ago, and more remarkably in the last five years. Although not always resulting in refusal, vaccine hesitancy also appears to contribute to delayed immunization or usage of alternative schedules.

Numerous reasons contribute to this phenomenon, including coincidental temporal association between adverse outcomes and vaccine administration, presence of vaccine mandates, poor knowledge of vaccine preventable diseases and lack of trust in public health agencies. Controversies and myths on vaccination safety are spread easily in social media and through disinformation campaigns. Ironically, the success of vaccines also contributes to VH in which effective immunization programs lead to limited exposure and knowledge of vaccine-preventable diseases, thus many parents ended up questioning their necessity. Other contributing factors include concern for safety, perceived lack of involvement in the decision-making process, lack of adequate time and resources, and religious or philosophical objections.

Research has shown that patients who receive a strong recommendation from a healthcare provider are 4-5 times more likely to be vaccinated. A study involving 20 pediatric primary care practices found that one of the most common recommended potential practice-level strategies to tackle VH is to provide training to improve vaccine counseling effectiveness and efficiency. Strikingly, all respondents of the study admitted to never having received any formal training in vaccine counseling. The study stressed the importance of training future primary care providers on how to communicate with vaccine-hesitant parents, including to residents and medical students. Pediatric residents need to be well prepared to address these issues, and have the knowledge, confidence, and competency to encourage VH parents to vaccinate their children.

The primary goal of this project is to develop and evaluate an interactive educational program, which will include online training modules and standardized patient encounters, for the pediatric, family medicine and medicine/pediatric residents that provides evidence-based information and skill-building strategies that will teach and refine vaccine counseling skills to promote vaccine uptake among vaccination-hesitant patient and/or families. Based upon the Announce-Inquire-Mirror-Secure (AIMS) framework, the program will deliver this information for vaccine counseling in general and within the context of the HPV, Influenza, MMR, and COVID-19 vaccines, which are the most commonly associated with myths and controversies. The impact of the interactive vaccine education program on vaccine uptake will be evaluated through comparison of pre- and post-intervention vaccination rates in the Beaumont residency clinics where residents provide patient care, residents' vaccine safety and vaccine hesitancy knowledge and provider behavior and communication skills on this topic during standardized patient encounters.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
112 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Non-blinded, single group educational interventionNon-blinded, single group educational intervention
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Improving Vaccine Counseling Skills Among Pediatric, Medicine/Pediatric and Family Medicine Residents Pilot Study: Evaluation, Education, and Promotion of Vaccine Confidence Using Educational Modules and Standardized Patient Encounters
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Feb 28, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Interactive Vaccine Education Program for resident providers

Resident providers in pediatric, pediatric/medicine and family medicine clinics will be given interactive educational interventions using online training modules combined with standardized patient encounters to teach and refine vaccine counseling skills

Other: Immersive resident education
Using the AIMS framework (Announce, Inquire, Mirror, Secure), residents will complete online modules designed to improve vaccine education, promote vaccine confidence and improve vaccine counseling in general. There will also be modules dispelling myths and controversies specific to HPV, MMR, Covid and influenza vaccines that often limit or prevent vaccination uptake.

Other: Standardized patient (SP) encounter
After completion of the Immersive Resident Education modules, residents will participate in a telemedicine standardized patient encounter. They will interview a vaccine-hesitant "patient" and this encounter will be video recorded. At the end of the encounter, the SP will provide the resident with patient-centered feedback on their communication skills. The SP will also complete a communication checklist regarding each resident encounter and the research team will review the recorded encounters for accuracy of medical content conveyed during each encounter.

Outcome Measures

Primary Outcome Measures

  1. Changes in provider confidence following education [baseline and up to 4 months after education]

    Difference in total score between pre-education and post-education survey of resident confidence in patient vaccine counselling, as measured by a summation score of 8 questions answered on a 5-point Likert scale, where 1=strongly disagree and 5 = strongly agree; a higher score indicates more confidence (maximum 40 points). A positive difference indicates an increase in confidence after education, and a negative number indicates a decrease in confidence after education.

  2. Change in provider attitudes following education [baseline and up to 4 months after education]

    Difference in total score between pre-education and post-education survey of resident attitudes towards vaccination hesitancy, as measured by a summation score of 8 questions answered on a 5-point Likert scale, where 1=strongly disagree and 5 = strongly agree; a higher score indicates a positive attitude toward vaccines and a lower score indicates a negative attitude toward vaccination (maximum of 40 points). A positive difference indicates a more positive attitude after education, and a negative number indicates a more negative attitude after education.

  3. Change in provider knowledge regarding vaccination [baseline and up to 4 months after education]

    Difference in scores between pre-education and post-education on a 15-question, multiple choice evaluation of provider knowledge about vaccine safety and efficacy. A higher score indicates more provider knowledge. A positive difference indicates an increase in knowledge after education, and a negative number indicates a decrease in knowledge after education.

  4. Score on standardized patient checklist [after standardized patient encounter, an average of 3 to 4 months after enrollment]

    Total score on evaluation checklist for standardized patient encounter following education. Maximum score is 16 points, minimum score is 0.

Secondary Outcome Measures

  1. Change in Measles/Mumps/Rubella (MMR) vaccine rate with provider education in pediatric resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of MMR vaccination in the pediatric resident clinic

  2. Change in Measles/Mumps/Rubella (MMR) vaccine rate with provider education in medicine/pediatric resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of MMR vaccination in the medicine/pediatric resident clinic

  3. Change in Measles/Mumps/Rubella (MMR) vaccine rate with provider education in family medicine resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of MMR vaccination in the family medicine resident clinic

  4. Change in Human Papilloma Virus (HPV) vaccine rate with provider education in pediatrics resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of HPV vaccination in the pediatrics resident clinic

  5. Change in Human Papilloma Virus (HPV) vaccine rate with provider education in medicine/pediatric resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of HPV vaccination in the medicine/pediatric resident clinic

  6. Change in Human Papilloma Virus (HPV) vaccine rate with provider education in family medicine resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of HPV vaccination in the family medicine resident clinic

  7. Change in Coronavirus-19 (COVID) vaccine rate with provider education in pediatric resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of COVID vaccination in the pediatric resident clinic

  8. Change in Coronavirus-19 (COVID) vaccine rate with provider education in medicine/pediatric resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of COVID vaccination in the medicine/pediatric resident clinic

  9. Change in Coronavirus-19 (COVID) vaccine rate with provider education in family medicine resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of COVID vaccination in the family medicine resident clinic

  10. Change in Influenza vaccine rate with provider education in pediatric resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of Influenza vaccination in the pediatric resident clinic

  11. Change in Influenza vaccine rate with provider education in medicine/pediatric resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of Influenza vaccination in the medicine/pediatric resident clinic

  12. Change in Influenza vaccine rate with provider education in family medicine resident clinic [baseline to 18 months]

    Difference between pre-intervention and post-intervention rates of Influenza vaccination in the family medicine resident clinic

  13. Change in total vaccine rate with provider education [baseline to 18 months]

    Difference between total pre-intervention and total post-intervention vaccination rates following provider education

  14. Change in total vaccine rate with provider education in pediatric clinic [baseline to 18 months]

    Difference between total pre-intervention and total post-intervention vaccination rates following provider education in the pediatric clinic

  15. Change in total vaccine rate with provider education in medicine/pediatric resident clinic [baseline to 18 months]

    Difference between total pre-intervention and total post-intervention vaccination rates following provider education in the medicine/pediatric resident clinic

  16. Change in total vaccine rate with provider education in family medicine resident clinic [baseline to 18 months]

    Difference between total pre-intervention and total post-intervention vaccination rates following provider education in the family medicine resident clinic

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pediatric, medicine/pediatric, and family medicine residents of all training levels

  • Employed by Beaumont Hospitals - Royal Oak, Troy, Wayne, or Grosse Pointe.

Exclusion Criteria:
  • Residents not enrolled in pediatric, medicine/pediatric, or family medicine programs

  • Residents receiving training at hospitals other than Beaumont Hospital - Royal Oak, Troy, Wayne, or Grosse Pointe.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beaumont Health System Royal Oak Michigan United States 48073

Sponsors and Collaborators

  • William Beaumont Hospitals
  • Merck Sharp & Dohme LLC

Investigators

  • Principal Investigator: Andrea C Hernandez Troya, MD, William Beaumont Hospitals

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Andrea Hernandez-Troya, Pediatric Clinical Simulation Director, William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT06074237
Other Study ID Numbers:
  • 2023-160
First Posted:
Oct 10, 2023
Last Update Posted:
Oct 10, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andrea Hernandez-Troya, Pediatric Clinical Simulation Director, William Beaumont Hospitals
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 10, 2023